CKW-14783-68796
2 vaccinations
6 coded responses
19 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 950 / CA
- Registered
- 2022-01-19
- Relationship
- Child or adolescent in my care
- Guardian
- 8U2-19729-90359
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-19
Registered in v-safe
-
2022-01-19
Dose 1 — Pfizer-BioNTech
- 2022-01-19
-
2022-01-20
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Night sweats — Feeling: Good · Site: PainFree text: Night sweats-mildMedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-01-22
- 2022-01-23
-
2022-01-25
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Dizziness, Vision blurred — Feeling: FairFree text: On Monday Jan 24th should after woke up, felt lightheadedness and blurry visionMedDRA releases: 2024-11 · check-in free text available
- 2022-01-26
- 2022-02-03
-
2022-02-10
Survey response — day 21, dose 1, dependentMedDRA: Rash — Feeling: GoodFree text: Unusual new rash on the back, looks like acne, but wasn't evaluated by a doctor yet.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-11
Dose 2 — Pfizer-BioNTech
- 2022-02-11
-
2022-02-12
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Night sweats — Feeling: GoodFree text: Mild night sweatingMedDRA releases: 2024-11 · check-in free text available
-
2022-02-15
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Unevaluable event — Feeling: Good · Headache, Rash, not including the immediate area around the injection siteFree text: On the upper backMedDRA releases: 2024-11 · check-in free text available
- 2022-02-25
- 2022-03-04
- 2022-03-13
- 2022-03-25
- 2022-05-13
- 2022-08-12
-
2023-02-12
Survey response — 12 months, dose 2, dependentMedDRA: Blood folate decreased, Unevaluable event — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-19 | Pfizer-BioNTech | No |
| 2 | 2022-02-11 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Night sweats-mild
Release 11 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): On Monday Jan 24th should after woke up, felt lightheadedness and blurry vision
Release 11 — day 21, dose 1, dependent
Symptoms: Unusual new rash on the back, looks like acne, but wasn't evaluated by a doctor yet.
Release 11 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Mild night sweating
Systemic reaction (other): On the upper back
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood folate decreased | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Night sweats | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
| SRO | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release